Electronic well being information briefs for 5/three/2017: New X Prize, sensible sneakers, and a lot more


IBM Watson hosts AI X Prize. With the Tricorder X Prize concluded, the X Prize foundation is tackling one more incredibly hot matter in healthcare: synthetic intelligence. Despite the fact that the IBM Watson-sponsored $5 million prize allows members to deal with any dilemma they want, anticipate to see a range of entries in healthcare, in which AI is at this time a incredibly hot matter and in which IBM Watson has been invested for some time.

Capable Well being secures CMS acceptance. Silicon Valley company Capable Well being, which will help companies navigate complex payment plans, has been permitted by CMS as a MIPS Competent Registry less than the Benefit-centered Incentive Payment Method. This will permit the company to submit info to CMS, which will help provider customers to a lot more conveniently monitor their effectiveness and protected reimbursement. 

Pixie announces UTI-detecting sensible pads. New York-centered Pixie Scientific has concluded Fda registration for its Pixie Smart Pads, which will use sensors and software package to keep an eye on for UTIs in incontinent seniors. The pads incorporate a biosensor that can detect an analyte associated with UTIs. The devices are also remaining shipped to early entry customers.

Altra launches sensible coaching sneakers. In accordance to a review in Ars Technica, Altra has introduced a shoe identified as the Altra Tobin IQ which not only includes sensors that measure issues like length, pace, cadence, landing zone, and effect level, but also sends that info to an app that feeds it into an AI operating coach that can give the user strategies as they operate. A pair of Altra Tobin IQs operates about $220.

A lot more on that Iodine-Superior Rx merger. In a new column in Inc. Journal, Iodine CEO Thomas Goetz shared some a lot more specifics about his company’s new merger. He suggests Iodine started out exploring M&A when they recognized they experienced a reliable products and good user gratification and uptake but, since of sluggish sales cycles in healthcare, could not switch that into profit. “Three years of effort and hard work had been lastly bearing fruit,” the former WIRED editor writes, “But no one was actually purchasing the fruit.”

Recommended for you

Leave a Reply